Latest News

  • PARTNERSHIPS

    9 Dec 2025

    Halozyme Bets Big on the Future of Biologics Delivery
  • RESEARCH

    21 Nov 2025

    Why Drug Delivery Is the New Power Move
  • INNOVATION

    19 Nov 2025

    Can One Small Shot Last a Year? MIT Thinks So
  • INNOVATION

    14 Nov 2025

    Can Tiny Injections Replace Big Infusions

AI Redesigns How America Makes Its Medicines

Robotic arm in a bright automated laboratory used for advanced pharmaceutical or biotech processes.

TECHNOLOGY

12 Nov 2025

Duke scientists use AI to cut a carcinogenic additive by 75%, proving safer drug design is within reach

Nanoform and Takeda Bet on Miniature Science

RESEARCH

7 Nov 2025

Nanoform and Takeda Bet on Miniature Science

Nanoform and Takeda test nanoparticle delivery for biologics, with early in-vivo results due in 2025

The Next Big Breakthrough in Biologics Starts at Home

INNOVATION

5 Nov 2025

The Next Big Breakthrough in Biologics Starts at Home

Halozyme’s Elektrofi buy brings next-gen innovation to biologic drug delivery

Pill Power: Lexaria’s $4M Shot at Ending Injections

INVESTMENT

3 Nov 2025

Pill Power: Lexaria’s $4M Shot at Ending Injections

Lexaria secures $4M to turn injectable drugs into pills with its DehydraTECH delivery platform

Biologics in Minutes: Halozyme Bets Big on Speed

INNOVATION

31 Oct 2025

Biologics in Minutes: Halozyme Bets Big on Speed

Halozyme’s $900M Elektrofi buy aims to turn complex infusions into quick injections

The Tiny Tech Turning Biologics Into Simple Shots

TECHNOLOGY

29 Oct 2025

The Tiny Tech Turning Biologics Into Simple Shots

Acquisition of Electrofi adds next-gen drug formulation and smart injection technology to Halozyme’s tech portfolio

Can Drug Delivery Go Green and Go Home?

INSIGHTS

27 Oct 2025

Can Drug Delivery Go Green and Go Home?

Portal, Kindeva, and Credence reshape biologic care with smarter, greener delivery

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.